BD active manifestations | Count (%) | ESR (mean ± SD) mm/hr | p-value | CRP (mean ± SD) mg/L | p-value |
---|---|---|---|---|---|
Active BD | Â | Â | Â | Â | Â |
Yes | 450 (87.5%) | 28.9 ± 23.8 |  < 0.001* | 0 |  < 0.001* |
No | 64 (12.5%) | 7.8 ± 4.5 |  | 0.9 ± 1.2 |  |
Active ocular signs | Â | Â | Â | Â | Â |
Yes | 234 (45.5%) | 20.7 ± 18.4 |  < 0.001* | 0.6 ± 1 |  < 0.001* |
No | 280 (54.5) | 30.9 ± 26 |  | 1 ± 1.3 |  |
Active oral signs | Â | Â | Â | Â | Â |
Yes | 254 (49.4%) | 35.2 ± 23.9 |  < 0.001* | 1.2 ± 1.3 |  < 0.001* |
No | 260 (50.6%) | 17.2 ± 19 |  | 0.4 ± 0.9 |  |
Active genital signs | Â | Â | Â | Â | Â |
Yes | 99 (19.3%) | 43 ± 21.7 |  < 0.001* | 1.8 ± 1.2 |  < 0.001* |
No | 415 (80.7%) | 22.3 ± 22 |  | 0.6 ± 1.1 |  |
Active vascular signs | Â | Â | Â | Â | Â |
Yes | 36 (7%) | 60.4 ± 20.2 |  < 0.001* | 2.6 ± 1.1 |  < 0.001* |
No | 478 (93%) | 23.7 ± 21.1 |  | 0.7 ± 1.1 |  |
Active joint signs | Â | Â | Â | Â | Â |
Yes | 68 (13.2%) | 50.2 ± 20.2 |  < 0.001* | 1.8 ± 1.2 |  < 0.001* |
No | 446 (86.8%) | 22.6 ± 21.6 |  | 0.6 ± 1.1 |  |
Active dermal signs | Â | Â | Â | Â | Â |
Yes | 180 (35%) | 36.7 ± 20.2 |  < 0.001* | 1.4 ± 1.3 |  < 0.001* |
No | 336 (65%) | 20.7 ± 23 |  | 0.5 ± 1 |  |
Positive pathergy test | Â | Â | Â | Â | Â |
Yes | 106 (20.6%) | 23.3 ± 25.5 | 0.017* | 0.6 ± 1.2 | 0.011* |
No | 408 (79.4) | 27 ± 22.8 |  | 0.8 ± 1.2 |  |
Epididymitis** | Â | Â | Â | Â | Â |
Yes | 6 (1.2%) | 50.1 ± 16.9 | – | 2.3 ± 1 | – |
No | 508 (98.8%) | 26 ± 23.3 |  | 0.8 ± 1.2 |  |
Active CNS signs** | Â | Â | Â | Â | Â |
Yes | 7 (1.4%) | 58.7 ± 38.5 | – | 1.8 ± 1.8 | – |
No | 507 (98.6%) | 25.8 ± 22.9 |  | 0.8 ± 1.2 |  |
Active GI signs** | Â | Â | Â | Â | Â |
Yes | 2 (0.4%) | 99 ± 33.9 | – | 3.5 ± 0.7 | – |
No | 512 (99.6%) | 26 ± 22.9 |  | 0.8 ± 1.2 |  |
Total | 514 | 26.3 ± 23.4 |  | 0.8 ± 1.2 |  |